Literature DB >> 23146101

Recognition of imipenem and meropenem by the RND-transporter MexB studied by computer simulations.

Francesca Collu1, Attilio V Vargiu, Jürg Dreier, Michele Cascella, Paolo Ruggerone.   

Abstract

Basic understanding of the means by which multidrug efflux systems can efficiently recognize and transport drugs constitutes a fundamental step toward development of compounds able to tackle the continuous outbreak of new bacterial strains resistant to traditional antibiotics. We applied a series of computational techniques, from molecular docking to molecular dynamics simulations and free energy estimate methods, to determine the differences in the binding properties of imipenem and meropenem, two potent antibiotics of the carbapenem family, to MexB, the RND transporter of the major efflux system of Pseudomonas aeruginosa. We identified and characterized two affinity sites in the periplasmic domain of the transporter, sharing strong similarities with the distal and proximal binding pockets identified in AcrB, the homologue of MexB in Escherichia coli. According to our results, meropenem has a higher affinity to the distal binding pocket than imipenem while both compounds are weakly bound to the proximal pocket. This different behavior is mainly due to the hydration properties of the nonpharmacophore part of the two compounds, being that of imipenem less bulky and hydrophobic. Our data provide for the first time a rationale at molecular level for the experimental evidence indicating meropenem as a compound strongly affected by MexB contrary to imipenem, which is apparently poorly transported by the same pump.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23146101     DOI: 10.1021/ja307803m

Source DB:  PubMed          Journal:  J Am Chem Soc        ISSN: 0002-7863            Impact factor:   15.419


  13 in total

1.  Molecular mechanism of MBX2319 inhibition of Escherichia coli AcrB multidrug efflux pump and comparison with other inhibitors.

Authors:  Attilio V Vargiu; Paolo Ruggerone; Timothy J Opperman; Son T Nguyen; Hiroshi Nikaido
Journal:  Antimicrob Agents Chemother       Date:  2014-08-11       Impact factor: 5.191

Review 2.  Repositioning rifamycins for Mycobacterium abscessus lung disease.

Authors:  Uday S Ganapathy; Véronique Dartois; Thomas Dick
Journal:  Expert Opin Drug Discov       Date:  2019-06-14       Impact factor: 6.098

Review 3.  Recent advances toward a molecular mechanism of efflux pump inhibition.

Authors:  Timothy J Opperman; Son T Nguyen
Journal:  Front Microbiol       Date:  2015-05-05       Impact factor: 5.640

4.  Computational study of correlated domain motions in the AcrB efflux transporter.

Authors:  Robert Schulz; Attilio V Vargiu; Paolo Ruggerone; Ulrich Kleinekathöfer
Journal:  Biomed Res Int       Date:  2015-01-05       Impact factor: 3.411

Review 5.  Molecular Dynamics Computer Simulations of Multidrug RND Efflux Pumps.

Authors:  Paolo Ruggerone; Attilio V Vargiu; Francesca Collu; Nadine Fischer; Christian Kandt
Journal:  Comput Struct Biotechnol J       Date:  2013-03-03       Impact factor: 7.271

6.  Molecular Rationale behind the Differential Substrate Specificity of Bacterial RND Multi-Drug Transporters.

Authors:  Venkata Krishnan Ramaswamy; Attilio V Vargiu; Giuliano Malloci; Jürg Dreier; Paolo Ruggerone
Journal:  Sci Rep       Date:  2017-08-14       Impact factor: 4.379

7.  Molecular Determinants of the Promiscuity of MexB and MexY Multidrug Transporters of Pseudomonas aeruginosa.

Authors:  Venkata K Ramaswamy; Attilio V Vargiu; Giuliano Malloci; Jürg Dreier; Paolo Ruggerone
Journal:  Front Microbiol       Date:  2018-06-01       Impact factor: 5.640

8.  Substrate binding accelerates the conformational transitions and substrate dissociation in multidrug efflux transporter AcrB.

Authors:  Beibei Wang; Jingwei Weng; Wenning Wang
Journal:  Front Microbiol       Date:  2015-04-13       Impact factor: 5.640

Review 9.  Interaction of antibacterial compounds with RND efflux pumps in Pseudomonas aeruginosa.

Authors:  Jürg Dreier; Paolo Ruggerone
Journal:  Front Microbiol       Date:  2015-07-08       Impact factor: 5.640

Review 10.  Current Advances in Developing Inhibitors of Bacterial Multidrug Efflux Pumps.

Authors:  Hannah Y Mahmood; Shirin Jamshidi; J Mark Sutton; Khondaker M Rahman
Journal:  Curr Med Chem       Date:  2016       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.